B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.

Tian DS, Qin C, Dong MH, Heming M, Zhou LQ, Wang W, Cai SB, You YF, Shang K, Xiao J, Wang D, Li CR, Zhang M, Bu BT, Meyer Zu Hörste G, Wang W

Open source

DOI: 10.1038/s44321-024-00043-z
Published: 2024 Apr
Container: EMBO molecular medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s44321-024-00043-z,
  title = {B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.},
  author = {Tian DS and Qin C and Dong MH and Heming M and Zhou LQ and Wang W and Cai SB and You YF and Shang K and Xiao J and Wang D and Li CR and Zhang M and Bu BT and Meyer Zu Hörste G and Wang W},
  year = {2024},
  journal = {EMBO molecular medicine},
  doi = {10.1038/s44321-024-00043-z},
  url = {https://doi.org/10.1038/s44321-024-00043-z}
}

RIS

TY  - JOUR
TI  - B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.
AU  - Tian DS
AU  - Qin C
AU  - Dong MH
AU  - Heming M
AU  - Zhou LQ
AU  - Wang W
AU  - Cai SB
AU  - You YF
AU  - Shang K
AU  - Xiao J
AU  - Wang D
AU  - Li CR
AU  - Zhang M
AU  - Bu BT
AU  - Meyer Zu Hörste G
AU  - Wang W
PY  - 2024
JO  - EMBO molecular medicine
DO  - 10.1038/s44321-024-00043-z
UR  - https://doi.org/10.1038/s44321-024-00043-z
ER  -

APA

DS, T., C, Q., MH, D., M, H., LQ, Z., W, W., SB, C., YF, Y., K, S., J, X., D, W., CR, L., M, Z., BT, B., G, M. Z. H., & W, W. (2024). B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.. EMBO molecular medicine. https://doi.org/10.1038/s44321-024-00043-z

Source records

pubmed · retrieved 2026-09-27T00:01:36.706Z